U.S. Patent No. 10,874,687 B1 (‘687), issued on December 29, 2020, to inventors Jean-Pierre Sommadossi of Boston, Massachusetts, and Adel Moussa of Burlington, Massachusetts. The applicant/assignee is Atea Pharmaceuticals, Inc. of Boston, Massachusetts, an anti-viral drug developer. The claims are directed to a method of therapeutic use for treating COVID-19, comprising the purine nucleotide phosphoramidate …
Author: Yonaxis
U.S. Patent No. D907,885 S1
U.S. Patent No. D907,885 S1 (‘885) issued on January 21, 2021, for “Funerary Urn.” It was issued to inventor Alex Borzaga of Cavareno, Italy. The applicant/assignee is Fenicetek of Turin, Italy. This patent is a design patent under 35 U.S.C. §171, which protects the ornamental features of an article of manufacture. The features protect the …
U.S. Patent No. 10,780,052 B2
U.S. Patent No. 10,780,052 (‘052) B2, issued on September 22, 2020, to inventors Frank DeRosa, Michael Heartlein, and Shirang Karve of Cambridge, Massachusetts, and applicant/assignee, Translate Bio, Inc., of Lexington, Massachusetts. The ‘052 patent claims priority to a provisional application filed October 22, 2013. The claims are directed to a method of therapeutic delivery of …
U.S. Patent No. PP31,874 P3
U.S. Patent No. PP31,874 P3 (‘874) issued on June 16, 2020 for “Cannabis Plant Named ‘Holy Crunch.” It was issued to inventor Mark Anthony Lewis and Steven Robert Haba, of Westlake Village, California and applicant/assignee Biotech Institute, LLC of Westlake Village, California. The ‘874 patent is a plant patent under 35 U.S.C. §161, which protects …
U.S. Patent No. PP31,707 P3
U.S. Patent No. PP31,707 P3 (‘707) issued onapril 28, 2020, for “Cannabis Plant Named ‘Grape Lollipop’.” It was issued to inventor Mark Anthony Lewis and Steven Robert Haba, of Westlake Village, California and applicant/assignee Biotech Institute, LLC of Westlake Village, California. The ‘707 patent is a plant patent under 35 U.S.C. §161, which protects new …
U.S. Patent No. 10,625,177 B2
U.S. Patent No. 10,625,177 B2 (‘177) issued on April 21, 2020, for “Bioavailable Cannabis Plant Blend.” It was issued to inventor David Harold Moore of Henderson, Nevada. The inventor discusses in the background of the specification how he has Asperger’s Syndrome, a mild form of autism. This autism can lead to an autoimmune disorder causing …
Presidential Inauguration Day
This is something trivial, but important to the daily IP practice. Consistent with 5 U.S.C. §6103(c), which deems “January 20 of each fourth year after 1965, Inauguration Day, is a legal public holiday . . . . ,” the USPTO is closed. The Copyright Office is also closed for the presidential inauguration. Any deadlines that …
Consolidated Appropriations Act of 2021
On December 27, 2020, the Consolidated Appropriations Act of 2021, the annual defense spending bill, was signed into law. Focused on COVID-19 relief and funding the federal government operations, there are also several IP-related authorizations approved in the bill itself. First, the Copyright Alternative in Small Claims Enforcement Act of 2020 (CASE Act) creates a …
Small Entity Change for 2021
On December 21, 2020, the U.S. Patent and Trademark Office amended practice rule 37 C.F.R. §1.27, to expand the government use license exception. First, a Federal employee-inventor must be granted to the Federal government in the event that employee-inventor retains ownership rights in the invention. Further, and more significantly because it potentially covers more small-to-medium …
U.S. Patent No. 10,752,636 B2
U.S. Patent No. 10,752,636 B2 (‘636) issued on August 25, 2020, entitled ”HIV Inhibitor Compounds.” It was issued to inventors Elizabeth Bacon, Elbert Chin, Jeromy Cottell, Ashley Katana, Darryle Kato, John Link, Nathan Shapiro, Teresa Trejo Martin, and Zheng-Yu Yang. The applicant/assignee is Gilead Sciences, Inc., of Foster City, California. The ‘636 patent is a …